Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Apr 11, 2024
- Accession no.
- 0001415889-24-010689
- Filed
- Apr 11, 2024
- Trade date
- Apr 9-10, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.83M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (CHAIRPERSON & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2024 | Common Stock | MOption exerciseAcquired | +15,000 | $129.49 | +$1,942,350 | 15,130 | Direct | |
| Apr 9, 2024 | Common Stock | SSaleDisposed | −6,994 | $236.74F2 | −$1,655,759.56 | 8,136 | Direct | |
| Apr 9, 2024 | Common Stock | SSaleDisposed | −8,006 | $237.52F3 | −$1,901,585.12 | 130 | Direct | |
| Apr 10, 2024 | Common Stock | MOption exerciseAcquired | +13,800 | $129.49 | +$1,786,962 | 13,930 | Direct | |
| Apr 10, 2024 | Common Stock | SSaleDisposed | −208 | $233.09F4 | −$48,482.72 | 13,722 | Direct | |
| Apr 10, 2024 | Common Stock | SSaleDisposed | −102 | $234.26F5 | −$23,894.52 | 13,620 | Direct | |
| Apr 10, 2024 | Common Stock | SSaleDisposed | −527 | $235.69F6 | −$124,208.63 | 13,093 | Direct | |
| Apr 10, 2024 | Common Stock | SSaleDisposed | −1,732 | $236.73F7 | −$410,016.36 | 11,361 | Direct | |
| Apr 10, 2024 | Common Stock | SSaleDisposed | −1,291 | $237.68F8 | −$306,844.88 | 10,070 | Direct | |
| Apr 10, 2024 | Common Stock | SSaleDisposed | −9,940 | $237.52 | −$2,360,948.8 | 130 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2024 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 352,469 | Direct | |
| Apr 10, 2024 | Common Stock | MOption exerciseDisposed | −13,800 | $0.00 | $0 | 338,669 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $236.09 to $237.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $237.10 to $238.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $232.735 to $233.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $234.055 to $234.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $235.19 to $236.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $236.38 to $237.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $237.45 to $237.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.